Private Equity 3 Days

Last updated: June 15, 2026, 2:30 AM ET

European Tech & AI Funding

A wave of optimism lifted European‑focused startups as swing‑into‑gear funding highlighted confidence in the region’s tech sector, while a separate push to accelerate defence‑grade AI saw the UK government explore “startup‑speed” deployment models for military applications fast‑track AI. The dual narrative underscores investors’ appetite for both commercial innovation and strategic tech, positioning Europe as a growing hub for high‑growth, high‑impact ventures.

Series‑A Capital Deployments

Orbio secured a $21 million Series A round led by Dawn Capital to automate hiring and onboarding for frontline workers, reflecting growing private‑equity interest in HR‑tech efficiencies closed $21 M round. Across the Atlantic, the week’s biggest financings featured Ninja One’s $400 million raise and Digital Asset’s blockchain funding, yet the largest single deals remained in Europe, where multiple unicorn‑scale rounds signaled a shift of capital northward led European deals.

Healthcare & Med Tech Consolidation

SK Capital‑backed Spectrum Vascular added medical‑device specialist Piccolo Medical to its portfolio, expanding its vascular‑access product line and deepening its foothold in the U.S. market acquired Piccolo. In a parallel move, KKA and Winterberg‑backed Healthcare Holding Schweiz bought Compet Medical, broadening its harm‑reduction offerings to public institutions across Europe bought Compet. Both transactions illustrate private‑equity firms’ strategy of bundling complementary medtech assets to capture scale and cross‑sell services.

Strategic PE AllocationsCarlyle announced a target of roughly $15 billion for its ninth flagship buyout fund, reaffirming confidence in large‑cap leveraged‑buyout opportunities despite a volatile macro environment set $15bn target. Meanwhile, BlackRock restricted withdrawals from its $13 billion private‑credit fund for the second consecutive quarter as retail investors continued to seek liquidity, highlighting the tension between fund stability and investor demand capped redemptions. These moves signal divergent approaches: aggressive capital raising versus tighter cash‑flow management.*

Talent & Governance Moves

Great Hill appointed Lauren Reddy to head its people function, leveraging her experience at L.E.K. Consulting to strengthen talent acquisition across the firm’s portfolio companies named head of people. In a related personnel shift, Paul Murphy exited Lightspeed but indicated he will remain active as an investor, suggesting that seasoned dealmakers are retaining influence through independent capital despite leaving firm‑based roles departed Lightspeed. Such changes reflect the growing importance of human‑capital expertise in private‑equity operations.

Sector‑Specific Deal Activity

Warburg Pincus moved close to acquiring Japanese housing group JSB, signaling interest in stable, income‑generating real‑estate assets in Asia’s residential market neared JSB deal. L Catterton led a Series A round in Remedy Science, a dermatologist‑founded skincare brand, marking the firm’s continued bet on clinically backed consumer products backed Remedy. Additionally, a cluster of deals targeting pediatric speech‑therapy providers—led by General Atlantic, Aquitaine Capital and others—underscored private‑equity’s focus on niche health‑service segments with recurring revenue models pursued speech‑therapy assets. Collectively, these transactions illustrate PE firms’ calibrated pursuit of resilient, high‑margin niches across geography and industry.